Crossmark

Prognostic impact of pathological complete response in hormone receptor–positive/HER2-negative breast cancer treated with neoadjuvant chemotherapy: a multicenter cohort study

Crossref DOI link: https://doi.org/10.1038/s41598-026-63952-8

Published Online: 2026-08-01

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Uguztemur, Esma https://orcid.org/0000-0003-1822-3870
Arici, Ozgur https://orcid.org/0000-0001-9821-6368
Asik, Esra https://orcid.org/0000-0003-3030-2475
Karanci, Ece https://orcid.org/0000-0002-0930-1016
Yildirim, Atila https://orcid.org/0000-0002-6067-5646
License Information

Text and Data Mining valid from 2026-08-01

Accepted Manuscript valid from 2026-08-01
More Information

Article History

Received: 16 April 2026

Accepted: 22 July 2026

First Online: 1 August 2026

Declarations

Conflict of interest: The authors declares no conflict of interest.

Informed consent: Due to the retrospective design of the study, informed consent was waived by the ethics committee.

Document is current

Any future updates will be listed below